No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis

Department of Clinical Neurosciences, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
Annals of Neurology (Impact Factor: 9.98). 03/2013; 73(3). DOI: 10.1002/ana.23833
Source: PubMed


An association has previously been reported between susceptibility to multiple sclerosis and the rare mutant alleles of the CYP27B1 gene responsible for autosomal recessive vitamin D-dependent rickets type 1 (VDDR1). In an attempt to replicate this finding, we screened 495 multiplex families and 2,092 single affected families, together with 4,594 cases and 3,583 controls (a total of 17,073 individuals) but were unable to find any evidence supporting this putative association. Our data do not indicate that mutations responsible for VDDR1 influence the risk of developing multiple sclerosis. Ann Neurol 2013;

Download full-text


Available from: Kjell-Morten Myhr, Dec 01, 2014
  • Source
    • "As GWAS loci presumably have a higher probability of harboring rare, deleterious alleles than the rest of the genome, the authors concluded that rare variants unlikely account for a substantial fraction of missing heritability in autoimmune diseases (17). Along these lines, an initial report (18) of a rare, high-risk MS variant in the vitamin-D activating gene CYP27B1 was not confirmed in independent validation studies (19, 20). Future genome-wide studies need to test massive sample sizes, comparable with those used in recent GWAS, to conclusively assess the potential role of rare variants in MS. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Multiple sclerosis (MS) is the most common auto-inflammatory disease of the central nervous system, affecting more than 2 million individuals worldwide. It is a genetically complex disease, in which a substantial part of a person's liability to develop MS is caused by a combination of multiple genetic and non-genetic (e.g., environmental) risk factors. Increasing this complexity, many of the involved risk factors likely interact in an intricate and hitherto ill-defined fashion. Despite these complexities, and owing greatly to the advent and application of large-scale genome-wide association studies, our understanding of the genetic factors underlying MS etiology has begun to gain unprecedented momentum. In this perspective, I will summarize some recent advances and outline future challenges in MS genetics research.
    Frontiers in Neurology 07/2014; 5(130). DOI:10.3389/fneur.2014.00130
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJEVTIVES: Multiple sclerosis is a chronic inflammatory disease of the central nervous system with unknown cause and without any curable treatment. Research aiming at defining the pathogenesis of the disease is therefore needed. The Norwegian Multiple Sclerosis Registry and Biobank has been established for systematic collection of clinical and epidemiological data as well as biological samples. Data collection is based on informed consent from the individual patients and recordings by the treating neurologists. All researchers have, by application, access to data and biological samples from the Norwegian Multiple Sclerosis Registry and Biobank. By this combined effort from both patients and health care personnel, the Registry and Biobank aims to facilitate research for improved understanding of disease mechanisms and improved health care in multiple sclerosis.
    Acta neurologica Scandinavica. Supplementum 12/2012; 126(195):20-3. DOI:10.1111/ane.12030
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Multiple sclerosis (MS) is a common disease of the central nervous system and a major cause of disability amongst young adults. Genome-wide association studies have identified many novel susceptibility loci including rs2248359. We hypothesized that genotypes of this locus could increase the risk of MS by regulating expression of neighboring gene, CYP24A1 which encodes the enzyme responsible for initiating degradation of 1,25-dihydroxyvitamin D3. Methods: We investigated this hypothesis using paired gene expression and genotyping data from three independent datasets of neurologically healthy adults of European descent. The UK Brain Expression Consortium (UKBEC) consists of post-mortem samples across 10 brain regions originating from 134 individuals (1231 samples total). The North American Brain Expression Consortium (NABEC) consists of cerebellum and frontal cortex samples from 304 individuals (605 samples total). The brain dataset from Heinzen and colleagues consists of prefrontal cortex samples from 93 individuals. Additionally, we used gene network analysis to analyze UKBEC expression data to understand CYP24A1 function in human brain. Findings: The risk allele, rs2248359-C, is strongly associated with increased expression of CYP24A1 in frontal cortex (p-value= 1.45 x 10(-13)), but not white matter. This association was replicated using data from NABEC (p-value=7.2 x 10(-6)) and Heinzen and colleagues (p-value= 1.2 x 10(-4)) Network analysis shows a significant enrichment of terms related to immune response in eight out of the 10 brain regions. Interpretation: The known MS risk allele rs2248359-C increases CYP24A1 expression in human brain providing a genetic link between MS and vitamin D metabolism, and predicting that the physiologically active form of vitamin D3 is protective. Vitamin D3's involvement in MS may relate to its immunomodulatory functions in human brain. (C) 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license.
    Multiple Sclerosis and Related Disorders 01/2013; 3(2). DOI:10.1016/j.msard.2013.08.009 · 0.88 Impact Factor
Show more